News

Evotec has extended the research collaboration with Boehringer Ingelheim for a further 4 years, based on the success to date in the areas of CNS, inflammation, cardiometabolic and

Halozyme (Halozyme) and ProMetic Life Sciences (ProMetic) have entered into a long-term supply agreement for a proprietary synthetic ligand affinity adsorbent manufactured by ProMetic’s UK subsidiary, ProMetic BioSciences.

Natrol has been recently certified by the Natural Products Association (NPA) current Good Manufacturing Practices (cGMP) certification program which incorporates the FDA final cGMP rule. Jenia Khudagulyan, senior

NexBio has presented new data entitled ‘DAS181 (Fludase), a Sialidase, Decreases Airway Resistance and Has Potent Anti-inflammatory Effects in Animal Models of Asthma’. DAS181 (Fludase) is an investigational

Harro Hofliger has introduced a fully automatic production of inhalation blisters. This powder-in-blister platform is designed for clinical testing, small-series production of inhalation preparations. The company said that

MorphoSys has received clearance from Germany’s Paul-Ehrlich-Institute as well as a positive opinion from the ethics committees in Germany to commence a Phase 1b/2a human clinical trial in

ISTA Pharmaceuticals has presented additional results from Bepreve (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies. Bepreve is a non-sedating, highly selective antagonist of the histamine (H1)

Bend Research has entered into a collaboration with Vertex Pharmaceuticals (Vertex). Through the collaboration, Vertex will utilise Bend’s formulation development and manufacturing services for specific projects and clinical

The US Department of Health and Human Services (HHS) has reported the contract awards for up to 120,000 treatment courses of intravenous (IV) antiviral drugs to help treat